1358 — PW Medtech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for PW Medtech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	627	737	158	231	230
Depreciation
Amortisation
Non-Cash Items	-633	-736	33.5	-58.2	-39.3
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	55.9	4.73	-0.578	-60.1	10.2
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	78.2	37.2	269	211	318
Capital Expenditures	-7.88	-11.3	-61.9	-81.9	-72.1
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2,078	2,648	-1,020	55.2	51.8
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	2,070	2,636	-1,082	-26.7	-20.3
Financing Cash Flow Items	-10.7	-0.604	1.54	89.8	-0.374
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-578	-2,091	-85.2	17.5	-211
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,569	583	-903	208	92.3